Pune, India -- (SBWIRE) -- 05/11/2020 -- Infinium Global Research has recently published a global report on "Histone Deacetylase Inhibitors Market (Class - Class I HDACs, Class II HDACs, and Class III HDACs; Applications - Neurology, Oncology, Central Nervous System Disorders, and Other Diseases): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025."

Histone deacetylase inhibitors are a new class of anti-cancer agents that play a vital role in epigenetic or non-epigenetic regulation such as apoptosis, death and cell cycle arrest in cancer cells. The report provides in-depth information about the histone deacetylase inhibitors market which is expected to grow at a CAGR of 5.9% over the forecast period of 2019-2025.

To Know More Request Sample of this Report@ https://www.infiniumglobalresearch.com/reports/sample-request/16339

Increasing Demand for Improved and Effective Therapies

The growing prevalence of cancer globally drives the growth of the histone deacetylase inhibitors market. According to the World Health Organization, in 2018, 9.6 million deaths occurred due to cancer. The increasing demand for improved and effective therapies contributes to the growth of the histone deacetylase inhibitors market. The high affinity and specificity of the HDAC enzyme stimulate the growth of the histone deacetylase inhibitors market. The rising awareness about cancer propels the growth of the histone deacetylase inhibitors market.

"We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report Shall be Revised to 2020-2026. The Section on the Impact of COVID-19 on Histone Deacetylase Inhibitors Market is Included in the Report for Free."

Surge in the Number of Clinical Trials for Different Oncological Applications

Furthermore, the surge in the number of clinical trials for different oncological applications boosts the growth of the histone deacetylase inhibitors market. On the flip side, uncertainty and reimbursement issues with respect to HDAC inhibitors hamper the growth of histone deacetylase inhibitors market. Moreover, rising investment in HDAC manufacturing and a surge in research and development activities in HDACs creates several opportunities for the growth of the histone deacetylase inhibitors market.

Asia-Pacific Region is Expected to Hold a Premium Share

Geographically, the global histone deacetylase inhibitors market is divided into North America, Asia-Pacific, Europe, and the Rest of the World. Asia-Pacific region is expected to hold a premium share in the global histone deacetylase inhibitors market. The rising healthcare infrastructure and the surge in the number of cancer patients in the Asia-Pacific region contribute to the growth of the histone deacetylase inhibitors market in Asia-Pacific.

North America is anticipated to grow in the global histone deacetylase inhibitors market with a healthy CAGR over the forecast period. The increasing research and development activities and growing technological advancement stimulate the growth of the histone deacetylase inhibitors market. Europe is growing in the global histone deacetylase inhibitors market.

Get this Section as a Free Customization in the Report Along With a 30% Discount on the Study. https://www.infiniumglobalresearch.com/reports/customization/16339

"We Have Decided to Extend Our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Histone Deacetylase Inhibitors Amidst COVID-19"

Histone Deacetylase Inhibitors Market Coverage

Chapter - 1     Preface

=> Report Description

=> Research Methods

=> Research Approaches

Chapter - 2     Executive Summary

=> Histone Deacetylase Inhibitors Market Highlights

=> Histone Deacetylase Inhibitors Market Projection

=> Histone Deacetylase Inhibitors Market Regional Highlights

Chapter - 3     Global Histone Deacetylase Inhibitors Market Overview

=> Introduction

=> Market Dynamics

=> Porter's Five Forces Analysis

=> IGR-Growth Matrix Analysis

=> Value Chain Analysis of Histone Deacetylase Inhibitors Market

Chapter - 4     Histone Deacetylase Inhibitors Market Macro Indicator Analysis

Chapter - 5     Global Histone Deacetylase Inhibitors Market by Class

=> Class I HDACs

=> Class II HDACs

=> Class III HDACs

Chapter - 6     Global Histone Deacetylase Inhibitors Market by Applications

=> Neurology

=> Oncology

=> Central Nervous System Disorders

=> Other Diseases

Chapter - 7     Global Histone Deacetylase Inhibitors Market by Region 2019-2025

=> North America

=> Europe

=> Asia-Pacific

=> RoW

Chapter - 8     Company Profiles and Competitive Landscape

=> Novartis International AG

=> Celgene Corporation

=> AstraZeneca plc

=> Acetylon Pharmaceuticals, Inc.

=> FORUM Pharmaceuticals, Inc.

=> Celleron Therapeutics Ltd.

=> Merck & Co., Inc.

=> Spectrum Pharmaceuticals, Inc.

=> Shenzhen Chipscreen Biosciences Co. Ltd.

=> Oncolys BioPharma Inc.

=> Other Companies

Chapter - 9     Appendix

=> Primary Research Findings and Questionnaire

Browse Complete Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-histone-deacetylase-inhibitors-market

About Infinium Global Research
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.